CDK7 (13B10) Rabbit Monoclonal Antibody

CDK7 (13B10) Rabbit Monoclonal Antibody

Cat: AMRe08570
Boyut:50μL Fiyat:$128_x000D_
Boyut:100μL Fiyat:$230_x000D_
Boyut:200μL Fiyat:$380_x000D_
Uygulama:WB,IHC,FC,IP
Reaktivite:Human,Mouse,Rat
Konjuge:Unconjugated
İsteğe bağlı konjugeler: Biotin, FITC (ücretsiz). Diğer 26 konjugatı görün.

Gen Adı:CDK7
Category: 組換えモノクローナル抗体 Tags: , , , , , , , , , ,
CDK7 (13B10) Rabbit Monoclonal Antibody
Konjugasyon: Unconjugated
Recombinant rabbit monoclonal antibody
Uygulama
IHC  ICC/IF  ELISA WB,IHC,FC,IP
Reaktivite
Human,Mouse,Rat
Gen Adı
CDK7
Saklama
Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Özet
Ürün Adı CDK7 (13B10) Rabbit Monoclonal Antibody
Açıklama Recombinant rabbit monoclonal antibody
Konak Rabbit
Reaktivite Human,Mouse,Rat
Konjugasyon Unconjugated
Modifikasyon Unmodified
İzotip IgG
Klonalite Monoclonal
Form Liquid
Konsantrasyon Unconjugated
Saklama Aliquot and store at -20°C (valid for 12 months). Avoid freeze/thaw cycles.
Nakliye Ice bags.
Tampon Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% New type preservative N and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.
Saflaştırma Affinity purification
Antijen Bilgisi
Gen Adı CDK7
Alternatif İsimler Cyclin-dependent kinase 7; p39 Mo15; CDK-activating kinase 1; Cell division protein kinase 7; CDK7; CAK; CAK1; CDKN7; MO15; STK1;
Gen Kimliği 1022
SwissProt Kimliği P50613
İmmünojen Recombinant protein of human CDK7
Uygulama
Uygulama WB,IHC,FC,IP
Seyreltme Oranı WB 1:500-1:2000,IHC 1:50-1:200,FC 1:20-1:50,IP 1:20-1:50
Moleküler Ağırlık 39kDa
Araştırma Alanı
Nucleotide excision repair;Cell_Cycle_G1S;Cell_Cycle_G2M_DNA;
Arka Plan
CDK-activating kinase (CAK) is a complex of CDK7 and cyclin H. The complex is involved in cell cycle regulation by phosphorylating an activating residue in the T-loop domain of cdks. Regulation of CAK activity is mediated by T-loop phosphorylation and by association with MAT1, both of which enhance its kinase activity toward the CTD of RNA polymerase II and other substrates such as p53. Serine/threonine kinase involved in cell cycle control and in RNA polymerase II-mediated RNA transcription. Cyclin-dependent kinases (CDKs) are activated by the binding to a cyclin and mediate the progression through the cell cycle. Each different complex controls a specific transition between 2 subsequent phases in the cell cycle. Required for both activation and complex formation of CDK1/cyclin-B during G2-M transition, and for activation of CDK2/cyclins during G1-S transition (but not complex formation). CDK7 is the catalytic subunit of the CDK-activating kinase (CAK) complex. Phosphorylates SPT5/SUPT5H, SF1/NR5A1, POLR2A, p53/TP53, CDK1, CDK2, CDK4, CDK6 and CDK11B/CDK11. CAK activates the cyclin-associated kinases CDK1, CDK2, CDK4 and CDK6 by threonine phosphorylation, thus regulating cell cycle progression. CAK complexed to the core-TFIIH basal transcription factor activates RNA polymerase II by serine phosphorylation of the repetitive C- terminal domain (CTD) of its large subunit (POLR2A), allowing its escape from the promoter and elongation of the transcripts. Phosphorylation of POLR2A in complex with DNA promotes transcription initiation by triggering dissociation from DNA. Its expression and activity are constant throughout the cell cycle. Upon DNA damage, triggers p53/TP53 activation by phosphorylation, but is inactivated in turn by p53/TP53; this feedback loop may lead to an arrest of the cell cycle and of the transcription, helping in cell recovery, or to apoptosis. Required for DNA-bound peptides-mediated transcription and cellular growth inhibition.
   💬 WhatsApp